Haemangioma and lymphangioma, any site

CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA

vulvar carcinoma: A carcinoma that arises from epithelial cells of the mammalian vulva

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D18 Cause of death: ICD-10 — D18 2 out of 7 registries used, show all original rules.	3160
4. Check minimum number of events None	3160
5. Include endpoints CD2_BENIGN_HEMANGIOMA CD2_BENIGN_LYMPHANGIOMA	3588
6. Filter based on genotype QC (FinnGen only)	3588

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D10-D36
Name in latin: Haemangioma sive lymphangioma, quovis loco

NAME	CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	CD2_BENIGN_HEMANGIOMA\|CD2_BENIGN_LYMPHANGIOMA
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D18
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D18
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Haemangioma and lymphangioma, any site based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	31154	18400	12629
Only index persons	26146	15515	10631
Unadjusted period prevalence (%)
Whole population	0.45	0.53	0.35
Only index persons	0.50	0.57	0.41
Median age at first event (years)
Whole population	37.79	37.79	37.66
Only index persons	42.29	42.73	41.64

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3588	2308	1280
Unadjusted period prevalence (%)	0.71	0.79	0.56
Median age at first event (years)	51.03	48.63	55.34

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3201: Matched controls
32011

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D18.0

ICD-10 Finland

Haemangioma, any site

1822.2

323.0

2622

22700

ICD-8 Finland

Haemangioma and lymphangioma, Haemangioma

+∞

239.6

227

D18.1

ICD-10 Finland

Lymphangioma, any site

+∞

215.0

204

2280A

ICD-9 Finland

Haemangioma and lymphangioma, any site, Haemangioma, any site

+∞

205.4

195

D18

ICD-10 Finland

Haemangioma and lymphangioma, any site

78.4

61.2

EAA10

NOMESCO Finland

Excision of lesion of lip

11.0

57.1

111

104

ZXC12

NOMESCO Finland

Pulse colorlaser

23.1

48.4

Q27.3

ICD-10 Finland

Peripheral arteriovenous malformation

75.6

46.1

Q27.4

ICD-10 Finland

Congenital phlebectasia

86.4

45.9

Q82.50

ICD-10 Finland

Naevus flammeus

40.6

38.5

QAA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of head or neck

14.4

38.2

Q27.9

ICD-10 Finland

Congenital malformation of peripheral vascular system, unspecified

135.0

37.8

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

7.1

34.5

124

22701

ICD-8 Finland

Haemangioma and lymphangioma, Lymphangioma

+∞

34.4

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

2.5

34.3

298

1283

2281A

ICD-9 Finland

Haemangioma and lymphangioma, any site, Lymphangioma, any site

+∞

32.3

QX3LT

NOMESCO Finland

Subcutaneous sclerotherapy

48.0

31.6

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.2

28.9

320

1542

XX6KT

NOMESCO Finland

Other sclerotherapy

39.3

28.0

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.9

27.7

118

313

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

27.4

827

5640

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

4.2

24.8

238

Q82.51

ICD-10 Finland

Naevus portwine

16.3

23.2

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

22.7

1047

7828

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

3.5

20.0

283

Q82.58

ICD-10 Finland

Congenital non-neoplastic naevus

6.6

19.9

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.1

19.8

222

1074

D13.4

ICD-10 Finland

Benign neoplasm: Liver

9.6

19.8

9736

FHL

Subcutaneous tumor removal in operating room or anesthesia

4.6

19.4

147

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

18.1

607

4186

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.7

18.1

433

2735

UJF32

NOMESCO Finland

Coloscopy

1.5

18.0

695

4952

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

18.0

259

1388

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.9

17.4

110

393

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.9

17.0

183

D48.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue

3.7

16.7

206

Q27.88

ICD-10 Finland

Other specified congenital malformation of peripheral vascular system

27.7

16.5

S18

ICPC

Laceration/cut

1.4

15.7

1142

9158

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

8.8

15.7

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.8

15.6

104

385

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.2

15.5

153

699

A02BC02

ATC

pantoprazole; systemic

1.4

15.4

1803

15606

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

14.9

763

5728

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

14.7

700

5179

ZXA00

NOMESCO Finland

Right side

1.4

14.6

714

5311

SPAT1153

SPAT

Removal of sutures

1.4

14.5

865

6680

N02BE01

ATC

paracetamol; systemic, rectal

1.4

14.4

2539

23370

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.8

14.1

157

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

6.0

13.7

EP1LT

NOMESCO Finland

Percutaneous sclerotherapy of vascular malformation of head and neck

75.4

13.6

NDR20

NOMESCO Finland

Incomplete excision of soft tissue tumour of wrist or hand

3.9

13.6

143

9744

FHL

+∞

13.5

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

3.2

13.4

217

J01DB01

ATC

cefalexin; oral

1.4

13.2

2410

22077

ZQX00

NOMESCO Finland

0-4% of the skin

14.1

12.7

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.0

12.7

238

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

12.7

165

851

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

12.6

371

2464

XX4BW

NOMESCO Finland

12.3

12.6

ZXC50

NOMESCO Finland

Cryotherapy

2.7

12.6

325

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

2.3

12.4

112

494

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.0

12.4

159

818

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

12.2

1868

16542

J01MA02

ATC

ciprofloxacin; systemic

1.3

12.2

1010

8186

A02BC03

ATC

lansoprazole; oral

1.4

12.2

761

5891

WX110

NOMESCO Finland

Local anesthesy

1.3

12.2

1997

17858

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

11.9

390

2657

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

11.8

1077

8848

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

3.9

11.7

122

ZXC10

NOMESCO Finland

Use of laser

2.8

11.7

263

A02BC01

ATC

omeprazole; systemic

1.4

11.6

726

5616

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.9

11.4

245

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

2.1

11.2

124

602

N02AX02

ATC

tramadol; systemic, rectal

1.3

11.1

1091

9045

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.9

10.9

148

778

ZXA05

NOMESCO Finland

Left side

1.4

10.9

646

4941

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

10.7

217

1307

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

10.5

535

3987

PG1HT

NOMESCO Finland

Extensive endovascular embolisation of arterio-venous malformation not elsewhere classified

+∞

10.4

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

10.3

276

1787

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

10.2

625

4808

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

3.1

10.2

182

QBA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of trunk

13.1

10.1

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.3

10.0

146

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

9.9

1107

9296

M25.5

ICD-10 Finland

Pain in joint

1.3

9.8

755

6016

Q28.8

ICD-10 Finland

Other specified congenital malformations of circulatory system

26.1

9.8

SPAT1263

SPAT

Sampling

1.3

9.8

1153

9756

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

9.7

1077

9028

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

9.7

849

6894

XQ845

NOMESCO Finland

Dermatoscopy

3.6

9.7

118

A02BC05

ATC

esomeprazole; systemic

1.3

9.7

1069

8963

4704

FHL

Neck tumor removal

13.4

9.7

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

9.6

420

3034

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

9.6

2030

18447

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

9.5

309

2100

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.2

9.4

450

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

9.4

191

1150

WX002

NOMESCO Finland

Sedation and analgesia

1.4

9.4

501

3758

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.5

9.3

271

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

9.3

581

4476

9733

FHL

Excision of skin change in operating room or anesthesia

3.0

9.3

166

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

7.3

9.2

B02AA02

ATC

tranexamic acid; systemic

1.4

9.2

394

2839

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

9.2

331

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

9.2

1338

11596

UJD02

NOMESCO Finland

Gastroscopy

2.0

9.2

115

587

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

9.1

416

3033

N03AX12

ATC

gabapentin; oral

1.4

9.0

396

2866

M01AH05

ATC

etoricoxib; oral

1.3

9.0

1611

14301

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

8.9

573

4427

TEA00

NOMESCO Finland

Biopsy of lip

3.6

8.8

107

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

8.7

136

754

9749

FHL

Other measure in this category

5.4

8.7

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.9

8.6

115

601

P01AB01

ATC

metronidazole; oral, rectal

1.3

8.6

1063

9011

I86.8

ICD-10 Finland

Varicose veins of other specified sites

11.6

8.6

9734

FHL

Excision and local plastic or associated free skin grafting

4.4

8.5

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

8.5

212

1349

C07AB02

ATC

metoprolol; systemic

1.4

8.4

474

3589

R22.3

ICD-10 Finland

Localized swelling, mass and lump, upper limb

2.6

8.3

226

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

8.3

475

3599

JN5LT

NOMESCO Finland

Sclerotherapy with direct puncture body area

+∞

8.3

QX3KT

NOMESCO Finland

+∞

8.3

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

3.0

8.3

157

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

2.0

8.3

102

520

XQ848

NOMESCO Finland

Dermatological photography

2.3

8.3

302

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

8.2

393

2885

Z31.5

ICD-10 Finland

Genetic counselling

1.8

8.2

135

764

ZXA10

NOMESCO Finland

Bilateral

1.4

8.2

456

3445

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

8.2

236

1561

R03BA08

ATC

ciclesonide; inhalant

1.6

8.1

206

1321

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

8.0

1210

10481

R4120

NOMESCO Finland

Occupational therapy

1.7

7.9

154

919

J01DA01

ATC

[U] cefalexin; systemic

1.2

7.9

1739

15696

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

7.9

448

3394

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

7.9

888

7424

S04

ICPC

Lump/swelling localized

1.5

7.8

238

1593

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

7.8

144

843

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

4.7

7.8

M03BX02

ATC

tizanidine; oral

1.2

7.8

1713

15453

QAE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of head or neck

9.4

7.8

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

1.9

7.8

112

604

N03AX16

ATC

pregabalin; oral

1.3

7.8

592

4694

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

7.7

410

3069

D21.1

ICD-10 Finland

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

3.3

7.7

109

Q87.21

ICD-10 Finland

Klippel-Trénaunay-Weber syndrome

45.1

7.7

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.6

7.7

180

1132

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.8

7.6

124

700

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

7.6

1093

9402

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

2.2

7.6

335

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

7.5

963

8163

JDA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in stomach or pylorus

10.0

7.5

WX400

NOMESCO Finland

Inhalation anesthesy

1.8

7.5

118

658

EJB10

NOMESCO Finland

Excision of lesion of apex or body of tongue

4.6

7.5

M54.5

ICD-10 Finland

Low back pain

1.3

7.5

841

7021

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

7.4

1461

12992

PG1GT

NOMESCO Finland

Endovascular embolisation of arterio-venous malformation with radiological guidance not elsewhere classified

80.3

7.4

Q82.5

ICD-10 Finland

Congenital non-neoplastic naevus

6.5

7.4

K11.69

ICD-10 Finland

Mukocele UNS

5.3

7.4

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.7

7.3

155

947

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

7.3

1563

14014

N05BA04

ATC

oxazepam; oral

1.3

7.3

608

4876

PG1JT

NOMESCO Finland

Very extensive endovascular embolisation of arterio-venous malformation not elsewhere classified

+∞

7.3

K14.9

ICD-10 Finland

Disease of tongue, unspecified

6.2

7.2

R03BA02

ATC

budesonide; inhalant

1.4

7.2

444

3407

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

7.2

228

1542

I78.8

ICD-10 Finland

Other diseases of capillaries

7.3

7.2

TQW99

NOMESCO Finland

Other minor procedure on skin

1.8

7.2

117

663

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.4

7.2

229

R06.0

ICD-10 Finland

Dyspnoea

1.3

7.1

583

4665

K76.80

ICD-10 Finland

Hepatic cyst

3.6

7.0

J33.0

ICD-10 Finland

Polyp of nasal cavity

2.2

7.0

296

R51.80

ICD-10 Finland

Headache

1.4

7.0

377

2828

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

4.1

7.0

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

6.9

422

3232

S82

ICPC

Naevus/mole

1.4

6.9

303

2189

KMAK

NOMESCO Finland

1.2

6.8

1400

12468

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

4.0

6.8

DM1CM

NOMESCO Finland

Paranasal sinuses extensive MRI examination with 3 Tesla magnet

40.1

6.8

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

3.8

6.8

EP1AT

NOMESCO Finland

Punction of soft tissue of neck with ultrasound guidance

16.7

6.7

PA5AC

NOMESCO Finland

Angiography of arteries to the face with X-ray

16.7

6.7

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

6.7

275

1964

R01AD09

ATC

mometasone; nasal

1.2

6.7

1231

10828

C05AA08

ATC

fluocortolone; rectal, topical

1.4

6.7

348

2596

9474

FHL

Soft tissue tumor removal (subcutaneous tumor 9736 skin tumor 9733)

7.2

6.7

AA1AD

NOMESCO Finland

CT of head and brain

1.3

6.7

542

4327

J01EA01

ATC

trimethoprim; systemic

1.3

6.7

631

5144

A07AA02

ATC

nystatin; oral

1.6

6.6

145

896

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.7

6.6

133

805

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

6.6

451

3515

R42

ICD-10 Finland

Dizziness and giddiness

1.3

6.6

517

4112

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

6.5

111

639

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.9

6.4

486

9161/1-C71.6

ICD-O-3

Hemangioblastoma of cerebellum, NOS

70.0

6.4

Q28.9

ICD-10 Finland

Congenital malformation of circulatory system, unspecified

70.0

6.4

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.6

6.4

167

1082

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

6.4

243

1709

R01AD08

ATC

fluticasone; nasal

1.3

6.4

728

6068

R03AC02

ATC

salbutamol; inhalant

1.2

6.4

1423

12752

J01FA10

ATC

azithromycin; systemic

1.2

6.3

1619

14695

DM1CG

NOMESCO Finland

Paranasal sinuses and face area extensive MRI examination with high intensity magnet

9.3

6.3

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

6.3

1034

8977

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

6.3

542

4366

EAB20

NOMESCO Finland

Plastic repair of lip

18.0

6.3

J01AA02

ATC

doxycycline; systemic

1.2

6.3

2178

20355

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

2.4

6.2

200

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

6.2

136

843

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.2

6.2

252

M79.6

ICD-10 Finland

Pain in limb

1.2

6.2

890

7620

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

6.1

224

1562

CBB30

NOMESCO Finland

Excision of lesion of eyelid

2.1

6.1

334

EKB00

NOMESCO Finland

Excision of lesion of cheek

5.3

6.1

WX702

NOMESCO Finland

Supraglottic ventilation device

1.6

6.1

132

814

QAE30

NOMESCO Finland

Excision and repair of surgical scar in head or neck

7.7

6.1

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

6.1

248

1769

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.3

6.0

217

L57.0

ICD-10 Finland

Actinic keratosis

1.5

6.0

198

1351

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1919

15030

1.59

39.97

6.2

umol/l

10.8

11.4

1.27

1825

14240

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2626

22520

1.62

34.37

8.2

7.5

u/l

77.7

78.5

0.32

2505

21257

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1230

9052

1.55

31.19

2.7

2.6

u/l

62.3

58.1

0.68

1145

8354

(40768804) Tissue Pathology biopsy report

1556

12126

1.50

29.71

2.3

2.1

—

(3032080) INR in Blood by Coagulation assay

1427

11187

1.46

25.08

8.1

8.9

inr

1.2

1.58

397

3302

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1752

14353

1.43

23.87

7.0

6.9

mmol/l

1.2

0.00

1514

12167

(3013707) Erythrocyte sedimentation rate by Westergren method

2517

22051

1.47

23.80

4.5

4.1

mm/h

10.9

11.8

2.68

2361

20486

(3024561) Albumin [Mass/volume] in Serum or Plasma

1524

12402

1.40

20.40

5.3

4.9

g/l

35.9

35.7

0.65

1446

11549

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

198

978

2.08

19.97

2.4

3.5

u/ml

76.0

4284.2

0.85

166

828

(3013826) Glucose [Moles/volume] in Serum or Plasma

1993

17025

1.38

19.59

4.7

4.8

mmol/l

6.5

6.6

2.74

1855

15893

(3001604) Monocytes [#/volume] in Blood

1792

15045

1.38

19.58

6.2

6.0

e9/l

0.6

0.09

1580

12986

(3006315) Basophils [#/volume] in Blood

1795

15095

1.38

19.31

6.2

6.0

e9/l

0.0

0.53

1581

13027

(3013115) Eosinophils [#/volume] in Blood

1847

15625

1.38

19.04

6.4

6.2

e9/l

0.2

0.01

1661

13715

(3019198) Lymphocytes [#/volume] in Blood

1825

15481

1.36

18.11

6.3

6.0

e9/l

1.9

2.0

0.19

1638

13645

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1220

9758

1.38

17.30

3.5

3.3

u/l

28.7

35.0

2.87

1158

9283

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3195

29960

1.61

17.15

15.9

13.6

mg/l

22.1

22.7

0.54

2596

23529

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1645

13804

1.35

17.14

4.3

4.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2598

23431

1.39

16.88

4.4

4.1

pmol/l

14.7

0.17

2386

21461

(3013650) Neutrophils [#/volume] in Blood by Automated count

2004

17401

1.34

16.29

9.2

9.0

e9/l

3.9

4.0

1.35

1787

15187

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2245

19857

1.35

15.97

3.5

3.1

u/l

46.8

46.2

0.11

2124

18600

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2973

27574

1.46

15.55

5.3

4.8

mu/l

1.9

2.1

1.16

2764

25466

(3019550) Sodium [Moles/volume] in Serum or Plasma

3218

30371

1.58

15.12

17.2

15.3

mmol/l

139.7

0.30

3151

29605

(3023103) Potassium [Moles/volume] in Serum or Plasma

3225

30467

1.58

14.91

17.3

15.5

mmol/l

3.9

4.0

2.41

3153

29649

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

420

2834

1.55

14.46

3.6

4.0

ug/l

25.5

19.0

0.20

329

2262

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1537

13032

1.31

13.84

6.1

6.2

mmol/l

1.2

0.11

1410

11855

(3022096) Basophils/100 leukocytes in Blood

1604

13697

1.31

13.65

6.4

6.2

0.7

0.03

1506

12798

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1465

12416

1.30

12.96

2.5

2.3

nmol/l

77.8

77.0

0.52

1334

11253

(40761511) CBC panel - Blood by Automated count

3275

31203

1.57

12.80

15.1

12.6

—

(3006504) Eosinophils/100 leukocytes in Blood

1636

14104

1.29

12.59

6.4

6.1

2.9

0.18

1538

13163

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

190

1087

1.79

12.42

3.3

5.8

1.7

1.6

0.14

182

1009

(42870588) Differential panel, method unspecified - Blood

1222

10159

1.31

12.29

6.0

—

(3019069) Monocytes/100 leukocytes in Blood

1639

14191

1.29

11.97

6.7

6.4

8.6

8.5

0.30

1549

13313

(3002030) Lymphocytes/100 leukocytes in Blood

1680

14595

1.28

11.94

6.5

6.2

28.3

28.6

0.58

1578

13627

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

836

6607

1.35

11.94

1.9

1.8

mg/l

1.3

1.2

0.29

640

4980

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

469

3363

1.45

11.92

2.9

umol/l

5.9

7.9

2.74

406

2917

(3033658) Prothrombin time (PT) actual/Normal

928

7452

1.33

11.88

4.6

4.0

94.1

91.4

2.63

901

7261

(40768797) Stomach Pathology biopsy report

553

4106

1.41

11.58

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2249

20335

1.28

11.33

5.0

4.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

185

1081

1.75

11.27

3.4

5.9

0.9

0.01

178

1006

(3018010) Neutrophils/100 leukocytes in Blood

1652

14391

1.27

11.22

6.4

6.0

57.0

56.7

0.36

1552

13487

(3002582) Erythrocytes [#/volume] in Urine

1052

8659

1.30

11.15

3.4

3.2

e6/l

136.4

85.2

0.19

797

6646

(3015736) pH of Urine

1321

11200

1.28

11.15

3.9

3.3

—

5.8

—

(3048689) Calprotectin [Mass/mass] in Stool

514

3803

1.41

10.95

2.6

2.4

ug/g

132.9

127.0

0.14

417

3019

(40760892) CBC W Ordered Manual Differential panel - Blood

844

6760

1.32

10.85

4.6

4.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

633

4865

1.37

10.71

2.7

e6/l

1.0

1.2

0.79

365

2773

(3031040) Bacteria [#/volume] in Urine by Automated count

2151

19407

1.27

10.69

4.9

4.4

e6/l

853.5

1904.0

0.87

259

(3018095) Leukocytes [#/volume] in Urine

1218

10288

1.28

10.40

4.0

3.7

e6/l

68.2

100.3

1.26

867

7193

(3030467) Casts [#/volume] in Urine by Automated count

969

7958

1.30

10.29

3.2

3.1

e6/l

0.3

0.4

1.83

730

6007

(3002256) Pathology report gross observation

510

3808

1.40

10.27

1.4

1.3

—

(3018418) pH of Serum or Plasma

1019

8441

1.29

10.10

4.0

7.4

0.69

178

1623

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1349

11569

1.27

10.09

2.0

1.9

pmol/l

95.4

96.4

0.31

698

5973

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

687

5395

1.34

10.03

3.7

3.6

ng/l

498.2

439.6

0.12

480

3991

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

869

7055

1.31

10.02

1.3

u/ml

1.0

1.7

1.86

206

1859

(3018677) aPTT in Platelet poor plasma by Coagulation assay

568

4343

1.37

9.87

2.3

29.9

29.7

0.10

549

4216

(3007461) Platelets [#/volume] in Blood

3437

33352

1.72

9.82

23.8

19.9

e9/l

254.8

255.2

0.15

3368

32534

(3005719) IgG [Mass/volume] in Serum or Plasma

327

2271

1.48

9.74

2.6

2.8

g/l

10.5

10.4

0.21

301

2084

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3294

31662

1.49

9.70

11.6

10.2

u/l

25.4

26.0

1.21

3205

30612

(3024731) MCV [Entitic volume]

3437

33368

1.71

9.58

23.6

19.8

90.6

90.8

1.07

3400

32928

(3035941) MCH [Entitic mass]

3437

33370

1.71

9.55

23.6

19.8

30.2

1.36

3399

32926

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1025

8547

1.28

9.54

2.0

2.1

u/l

145.4

218.6

3.21

961

8047

(3027273) Bicarbonate [Moles/volume] in Venous blood

205

1289

1.63

9.53

3.4

mmol/l

25.5

25.3

0.33

200

1248

(3026361) Erythrocytes [#/volume] in Blood

3437

33373

1.71

9.51

23.7

19.9

e12/l

4.5

0.71

3354

32476

(3010813) Leukocytes [#/volume] in Blood

3437

33379

1.70

9.42

23.8

19.9

e9/l

6.7

0.26

3355

32480

(3035350) Ketones [Presence] in Urine by Test strip

1640

14466

1.25

9.37

4.1

3.6

estimate

0.0

0.50

291

2701

(3000963) Hemoglobin [Mass/volume] in Blood

3437

33384

1.70

9.34

23.9

20.0

g/l

135.0

0.01

3399

32940

(3009261) Glucose [Presence] in Urine by Test strip

1657

14651

1.24

9.20

4.2

3.6

estimate

0.0

1.32

303

2680

(3007164) IgA [Mass/volume] in Serum or Plasma

761

6135

1.31

9.14

1.5

g/l

2.3

0.11

460

3738

(3030981) Hyaline casts [#/volume] in Urine by Automated count

217

1400

1.59

9.08

3.0

2.8

e6/l

0.2

0.3

1.50

211

1358

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

383

2782

1.42

9.00

2.5

2.4

g/l

0.2

0.89

364

2613

(3044640) Blood type and Crossmatch panel - Blood

1095

9277

1.26

8.78

2.6

2.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

103

3.22

8.75

1.3

1.2

108.0

106.8

0.06

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

150

891

1.71

8.69

3.0

3.2

g/l

3.2

3.5

2.19

142

845

(3021601) Nitrite [Presence] in Urine by Test strip

1635

14506

1.23

8.57

5.7

4.8

estimate

0.0

0.42

310

2758

(3007853) Bacteria identified in Skin by Aerobe culture

456

3441

1.37

8.55

1.9

1.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1225

10552

1.24

8.41

3.7

3.5

ng/l

100.2

99.4

0.00

782

6828

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

577

4538

1.32

8.21

3.1

2.9

e6/l

3.7

2.8

0.71

311

2463

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

280

1955

1.47

8.13

3.2

pmol/l

4.4

4.5

0.50

253

1741

(3037522) Nuclear Ab [Titer] in Serum

536

4182

1.33

8.05

1.4

1.3

titre

521.9

536.7

0.06

105

902

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

103

561

1.86

8.01

2.9

3.5

u/ml

50.3

802.4

0.98

516

(3004789) Transferrin [Mass/volume] in Serum or Plasma

524

4098

1.33

7.73

2.6

2.5

g/l

2.4

1.01

485

3803

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

101

3.09

7.69

1.2

1.3

93.0

89.7

0.16

(3014576) Chloride [Moles/volume] in Serum or Plasma

456

3511

1.34

7.48

6.2

7.1

mmol/l

104.6

104.4

0.63

449

3436

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

103

3.03

7.45

1.2

1.1

94.4

90.8

0.22

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

410

3113

1.36

7.37

3.6

4.3

u/l

233.8

250.1

1.17

389

2939

(3028026) IgM [Mass/volume] in Serum or Plasma

256

1795

1.46

7.29

1.9

1.8

g/l

1.3

1.4

0.13

243

1647

(36304419) Bacteria [Presence] in Urine

922

7799

1.25

7.25

3.1

—

(3026008) Bacteria identified in Urine by Culture

1017

8703

1.24

7.17

3.4

3.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

114

665

1.74

7.11

5.5

4.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1137

9852

1.23

7.10

3.3

mmol/l

2.4

0.02

1002

8678

(3044889) 12 lead EKG panel

2205

20381

1.21

7.06

3.8

3.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1499

13359

1.21

7.03

3.3

2.8

ug/l

105.0

116.0

1.26

1411

12429

(3034770) Mitochondria Ab [Titer] in Serum

136

835

1.65

7.03

1.3

1.2

titre

1020.0

1131.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3023

28908

1.29

7.00

4.5

4.2

mmol/l

1.5

0.12

2822

26822

(3019150) Specific gravity of Urine by Refractometry

759

6302

1.26

7.00

4.6

3.9

kg/l

1.0

0.24

111

911

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

485

3813

1.31

6.87

2.7

2.6

22.7

23.2

0.33

404

3289

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2926

27885

1.27

6.85

4.0

3.8

mmol/l

1.3

0.20

2710

25722

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

895

7586

1.24

6.85

2.9

3.1

ng/l

1242.0

1280.1

0.09

758

6446

(3002385) Erythrocyte distribution width [Ratio]

2669

25185

1.23

6.78

19.1

16.3

13.7

13.6

0.97

2637

24643

(3013139) Helicobacter pylori Ag [Presence] in Stool

281

2033

1.41

6.76

1.3

1.2

—

(3000494) Fungus identified in Specimen by Culture

445

3465

1.32

6.74

1.5

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

140

881

1.61

6.58

3.0

163.8

183.9

2.22

133

844

(3022948) Iron [Moles/volume] in Serum or Plasma

556

4478

1.29

6.55

2.7

2.5

umol/l

13.1

13.4

0.55

512

4161

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1263

11132

1.21

6.51

4.4

3.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3078

29572

1.29

6.38

5.0

4.7

mmol/l

2.8

0.27

2880

27398

(3003338) MCHC [Mass/volume]

2721

25781

1.23

6.37

20.2

17.2

g/l

332.2

332.4

0.47

2705

25594

(3026782) Osmolality of Urine

678

5612

1.26

6.37

3.1

2.8

mosm/kgh2o

485.4

542.8

0.43

594

4780

(3007566) Smooth muscle Ab [Titer] in Serum

132

834

1.60

6.13

1.3

1.2

titre

106.0

87.8

—

(3000850) Epithelial cells [#/volume] in Urine

723

6053

1.24

6.12

2.6

e6/l

4.7

6.2

2.99

648

5297

(3022145) Colonoscopy Study observation

414

3237

1.32

6.09

1.4

1.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

278

2046

1.39

6.07

1.6

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3032

29117

1.27

6.02

4.5

4.3

mmol/l

4.7

0.22

2844

27161

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

3.25

5.99

1.1

1.4

104.0

103.6

0.02

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2974

28505

1.25

5.95

4.7

4.3

mmol/l

5.9

0.37

2749

26140

(3022217) INR in Platelet poor plasma by Coagulation assay

437

3456

1.30

5.91

24.1

23.3

inr

1.3

0.20

513

(40768443) Skin Pathology biopsy report

178

1216

1.49

5.83

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

120

755

1.61

5.69

1.2

—

(4010399)

277

2060

1.37

5.69

1.5

1.4

—

(3036489) Thrombin time

167

1133

1.50

5.67

2.5

21.0

21.5

0.60

142

998

(3000570) Elastase.pancreatic [Mass/mass] in Stool

134

868

1.56

5.63

1.5

1.4

ug/g

305.8

290.9

0.41

488

(3011397) Hemoglobin [Presence] in Urine by Test strip

799

6815

1.22

5.62

4.1

3.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

208

1476

1.43

5.61

2.4

—

(3023368) Bacteria identified in Blood by Culture

871

7497

1.21

5.59

4.4

4.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2799

26701

1.22

5.58

5.9

5.5

mmol/mol

39.2

39.4

0.81

2629

24825

(3024354) Oxygen [Partial pressure] in Venous blood

297

2248

1.35

5.46

3.6

3.7

kpa

4.8

4.7

0.36

289

2182

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

857

7383

1.21

5.43

2.8

2.2

mg/l

3.0

2.9

0.33

758

6323

(3019060) Gas panel - Arterial blood

243

1785

1.39

5.40

4.4

5.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

551

4544

1.25

5.29

1.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

296

2258

1.34

5.18

2.7

2.9

ng/l

153.5

187.8

0.87

267

2052

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2895

27771

1.22

5.14

14.1

12.4

ml/min/173m2

83.6

82.9

0.90

2431

22866

(3021447) Carbon dioxide [Partial pressure] in Venous blood

344

2689

1.31

5.08

3.8

4.3

kpa

5.8

0.19

335

2615

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

823

7115

1.20

4.98

2.6

2.3

—

(3013512) EKG study

926

8101

1.19

4.91

4.1

3.7

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

143

971

1.49

4.88

2.7

2.8

93.6

92.0

0.40

134

913

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

693

5904

1.22

4.87

1.7

1.5

—

(3039000) Anion gap in Blood

605

1.62

4.82

3.8

8.3

mmol/l

10.7

11.2

1.24

537

(3042936) Bacteria identified in Isolate by Culture

495

4076

1.25

4.81

2.0

—

(3018572) Chloride [Moles/volume] in Blood

606

1.62

4.80

3.8

8.3

mmol/l

105.6

105.4

0.19

538

(3027945) Reticulocytes/100 erythrocytes in Blood

385

3080

1.28

4.77

2.5

2.8

1.8

0.07

353

2739

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

602

5075

1.22

4.69

1.3

u/ml

7.2

10.7

0.71

239

2009

(3002173) Hemoglobin [Mass/volume] in Arterial blood

329

2586

1.30

4.67

6.3

8.7

g/l

121.1

121.9

0.33

321

2490

(3021440) Promyelocytes/100 leukocytes in Blood

304

2364

1.31

4.67

3.7

4.3

0.1

0.2

0.49

642

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

619

5236

1.22

4.66

2.9

3.0

mmol/l

2.4

0.53

544

4589

(3021589) Normoblasts [#/volume] in Blood

1470

13405

1.16

4.64

10.3

9.3

e9/l

0.0

2.14

1211

10916

(3025159) Blasts/100 leukocytes in Blood

288

2229

1.32

4.58

3.7

4.3

0.0

0.4

0.93

542

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

128

862

1.50

4.57

1.0

1.1

u/ml

5.0

4.4

0.05

114

(3002032) Base excess in Venous blood by calculation

338

2675

1.29

4.56

3.9

4.3

mmol/l

2.0

1.9

0.48

281

2147

(3023323) Follitropin [Units/volume] in Serum or Plasma

221

1647

1.36

4.53

1.4

iu/l

30.3

29.3

0.13

191

1405

(36660697) Celiac disease serology panel - Serum

322

2543

1.29

4.42

1.2

—

(3047181) Lactate [Moles/volume] in Blood

128

869

1.49

4.41

3.8

6.9

mmol/l

1.2

1.3

1.72

114

751

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

150

2.21

4.36

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

856

7509

1.18

4.33

2.7

2.6

umol/l

5479.6

4559.9

0.25

760

6575

(3005322) IgE [Units/volume] in Serum or Plasma

264

2038

1.32

4.29

1.3

u/ml

138.5

202.9

1.54

251

1882

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

101

2.49

4.29

1.6

2.3

—

(3017181) Myelocytes/100 leukocytes in Blood

314

2483

1.29

4.27

3.7

4.2

0.8

0.9

0.08

699

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

224

1690

1.35

4.26

1.1

1.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

173

1252

1.40

4.26

2.1

1.9

u/l

40.4

38.8

0.46

157

1121

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

416

1.70

4.23

1.2

1.1

g/l

1.4

1.5

1.66

376

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

114

763

1.51

4.22

2.1

mg/l

9.0

11.4

2.68

106

699

(3012095) Magnesium [Moles/volume] in Serum or Plasma

555

4692

1.22

4.19

3.4

3.7

mmol/l

0.8

0.32

508

4399

(3003327) Ova and parasites identified in Stool by Light microscopy

141

987

1.45

4.18

1.7

1.8

—

(3016502) Oxygen saturation in Arterial blood

348

2797

1.27

4.16

6.1

8.3

96.3

95.7

0.90

336

2697

(3003396) Base excess in Arterial blood by calculation

385

3133

1.26

4.15

5.8

7.8

mmol/l

1.1

1.0

0.05

302

2433

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2140

20159

1.15

4.13

3.2

3.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

743

6465

1.19

4.11

1.5

nmol/l

21.3

20.8

0.38

651

5548

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

154

2.15

4.11

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

620

5310

1.20

4.09

1.3

iu/ml

22.5

31.8

2.14

180

1664

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

385

3140

1.25

4.07

5.8

7.8

kpa

5.2

5.1

0.59

371

2994

(3027801) Oxygen [Partial pressure] in Arterial blood

385

3140

1.25

4.07

5.8

7.8

kpa

13.4

12.5

2.08

370

2994

(3036481) Cortisol [Moles/volume] in Serum or Plasma

353

2850

1.26

4.07

2.2

nmol/l

367.1

365.6

0.05

323

2612

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

252

1.88

4.02

1.5

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

224

1706

1.33

4.02

6.7

7.3

mmol/l

24.5

0.03

215

1585

(3004588) Protein electrophoresis panel - Serum or Plasma

239

1843

1.32

3.94

2.9

2.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.43

3.80

1.9

2.8

umol/l

28.1

30.7

0.46

(4035726)

322

2602

1.26

3.70

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

283

2253

1.28

3.68

3.0

2.7

g/l

66.8

66.6

0.17

253

2067

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

442

1.62

3.65

1.0

1.1

u/ml

1.8

3.0

0.96

202

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

160

1176

1.38

3.64

2.2

u/l

5456.8

4714.7

0.11

456

(3023520) Reticulocytes [#/volume] in Blood

285

2280

1.27

3.57

2.4

2.8

e9/l

68.9

70.4

0.29

224

1730

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

379

3136

1.23

3.54

1.6

1.7

—

(44813793)

220

1.87

3.54

1.1

1.0

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

380

3149

1.23

3.50

1.6

1.8

—

(3049242) von Willebrand panel - Platelet poor plasma

10.01

3.49

2.2

3.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

165

2.01

3.49

1.1

1.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

161

1195

1.36

3.46

1.4

1.5

u/ml

4.5

17.8

—

(3019309) Folate [Moles/volume] in Red Blood Cells

582

5043

1.18

3.35

1.7

nmol/l

1173.7

1168.4

0.04

447

3824

(3000330) Specific gravity of Urine by Test strip

186

1419

1.33

3.35

4.4

3.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

114

804

1.43

3.32

1.2

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

281

2271

1.26

3.26

3.4

4.0

0.5

0.6

0.70

503

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.79

3.25

2.2

2.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

659

1.47

3.22

1.3

1.4

—

(3020891) Body temperature

149

1110

1.36

3.16

5.4

4.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

821

7346

1.15

3.13

5.1

4.8

ug/l

2.2

2.8

2.00

748

6602

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

133

975

1.38

3.12

2.8

2.4

g/l

10.3

0.05

110

838

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

305

1.68

3.11

4.7

4.4

u/ml

29.9

86.8

1.15

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

281

2288

1.25

3.06

2.3

2.4

ug/l

4.5

6.6

2.11

239

2029

(3020874) Milk IgE Ab [Units/volume] in Serum

217

1.81

3.05

1.3

1.1

u/ml

1.1

3.5

0.94

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

259

2091

1.26

3.04

2.5

2.4

au/ml

22.6

23.3

0.03

130

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

286

2336

1.24

3.04

3.2

2.6

ml/min/173m2

69.6

67.7

0.36

127

914

(3017143) Hepatitis C virus Ab [Presence] in Serum

414

3516

1.20

3.00

1.5

1.6

—

(3029937) Albumin [Presence] in Urine by Test strip

864

7783

1.14

2.98

4.6

4.0

estimate

0.0

1.49

297

2684

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

4.71

2.91

1.0

1.1

—

(4306422)

453

1.53

2.90

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

170

1.89

2.90

1.5

1.6

ug/l

6.2

9.0

1.06

147

(40761535) Cells panel - Urine sediment

288

2370

1.23

2.87

3.7

3.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

274

1.69

2.87

2.7

2.1

—

(3022313) Gas panel - Capillary blood

180

1400

1.30

2.87

5.0

4.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

140

1051

1.35

2.86

2.9

2.4

g/l

3.5

3.8

2.16

763

(3039162) Centromere protein B Ab [Units/volume] in Serum

383

1.58

2.86

1.5

1.3

u/ml

63.0

46.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

140

1052

1.34

2.84

2.9

2.4

g/l

7.5

7.4

0.27

802

(3003458) Phosphate [Moles/volume] in Serum or Plasma

447

3843

1.19

2.83

5.6

6.3

mmol/l

1.0

1.1

1.41

416

3582

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

188

1476

1.29

2.80

6.8

10.9

—

(3023511) Choriogonadotropin [Units/volume] in Urine

630

1.44

2.78

1.4

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

443

1.52

2.75

1.1

115.9

117.7

0.16

406

(3041096) Erythrocytes [Presence] in Urine by Automated

873

7909

1.14

2.74

3.7

3.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

157

1208

1.31

2.72

1.3

u/ml

0.7

1.2

—

104

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

273

2248

1.23

2.72

3.9

4.1

ng/l

86.1

84.8

0.09

239

1953

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

139

1052

1.33

2.70

3.0

2.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

121

901

1.35

2.63

2.3

2.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

408

1.53

2.61

1.4

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

126

946

1.34

2.60

1.6

g/l

1.1

1.2

0.60

118

894

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

677

6056

1.15

2.56

1.6

1.7

pmol/l

20922407.9

32438690.9

0.31

564

5102

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

185

1.79

2.56

6.9

6.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

5.46

2.54

1.7

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

122

915

1.35

2.54

1.4

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

2846

27670

1.14

2.54

16.9

14.4

39.5

39.8

0.57

2092

20515

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

526

4628

1.16

2.51

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

560

1.44

2.51

1.8

1.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

560

1.44

2.51

1.1

u/ml

1.8

2.8

0.58

139

(3043409) Potassium [Moles/volume] in Arterial blood

112

831

1.36

2.50

4.9

4.1

mmol/l

3.8

3.9

0.81

107

778

(40758558) Short blood count panel - Blood

846

7693

1.13

2.49

6.5

6.7

—

(3025941) Bacteria identified in Stool by Culture

213

1726

1.25

2.48

1.3

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

149

1155

1.30

2.48

1.7

1.6

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

233

1913

1.23

2.41

1.3

au/ml

26.9

47.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

475

1.46

2.37

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

467

1.46

2.37

1.3

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

656

5891

1.14

2.34

4.7

4.1

22.7

21.4

1.40

321

2777

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

154

1209

1.29

2.34

1.5

1.9

g/l

1.5

1.6

0.45

140

1051

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

327

2787

1.19

2.32

2.8

2.4

u/l

36.1

56.6

0.62

288

2389

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.22

2.30

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

266

2226

1.21

2.30

1.2

iu/ml

103.3

152.0

1.98

108

839

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

674

1.37

2.26

1.2

1.1

u/ml

1.3

2.0

0.34

293

(3022475) Manganese [Moles/volume] in Blood

3.89

2.25

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

858

7855

1.12

2.24

1.7

1.6

mmol/l

1.3

1.4

0.98

747

6656

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

277

2335

1.20

2.22

3.6

3.9

mmol/l

1.2

0.36

254

2040

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

422

3687

1.16

2.22

1.8

1.5

1.4

0.14

374

3265

(3008401) Mugwort IgE Ab [Units/volume] in Serum

593

1.39

2.18

1.1

u/ml

0.2

1.3

2.53

277

(3009343) pH of Capillary blood

227

1881

1.22

2.18

4.8

4.6

7.4

0.12

217

(4024509)

273

1.58

2.17

1.4

1.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

188

1.71

2.16

1.1

ratio

1.1

1.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

159

1268

1.27

2.16

2.5

3.0

0.7

0.72

153

1218

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

115

1.92

2.15

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

115

1.92

2.15

1.5

1.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

101

1.99

2.15

2.0

1.5

pmol/l

13.7

14.5

0.31

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

638

1.37

2.14

1.4

1.2

u/ml

24.8

3.5

—

(3037121) Protein [Mass/volume] in Urine

131

1022

1.29

2.12

3.5

3.6

g/l

0.5

0.3

0.60

433

(3012494) Peanut IgE Ab [Units/volume] in Serum

123

1.88

2.11

1.1

u/ml

2.3

8.1

0.44

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

228

1898

1.21

2.10

4.9

4.6

kpa

5.1

5.2

0.10

207

1770

(3025018) Bordetella pertussis Ab [Titer] in Serum

206

1.66

2.07

1.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

5.01

2.07

1.2

4.1

mmol/l

4.1

4.4

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

2.91

2.07

2.7

2.0

mg/l

1.7

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

609

1.37

2.05

1.1

u/ml

3.7

5.5

0.68

330

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

110

844

1.31

2.03

5.9

5.5

mg/l

1.4

1.5

0.10

104

785

(3019225) pH of Specimen

330

2851

1.17

2.02

5.0

4.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

155

1245

1.26

2.00

5.2

4.9

mmol/l

24.9

24.7

0.31

147

1172

(3033705) Calcium.ionized [Moles/volume] in Venous blood

311

1.52

2.00

2.8

2.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.96

2.00

1.9

2.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

561

1.38

1.99

1.4

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

232

1.60

1.98

1.1

1.2

—

(3049717) Cytology report of Urine Cyto stain

125

980

1.29

1.97

2.6

2.5

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

160

1293

1.25

1.97

2.5

3.0

1.4

1.2

0.83

160

1285

(3034274) Bile acid [Moles/volume] in Serum --fasting

378

1.46

1.96

2.2

2.6

umol/l

7.9

7.2

0.09

274

(3006922) Hepatitis E virus Ab [Presence] in Serum

210

1.62

1.94

1.0

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

210

1.62

1.94

1.1

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

607

1.36

1.93

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

607

1.36

1.93

1.2

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

135

1073

1.27

1.92

2.0

1.8

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

117

914

1.29

1.91

1.6

g/l

0.2

1.21

108

864

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

364

1.46

1.90

1.3

1.4

pmol/l

338.0

321.5

0.14

289

(3027135) IgG subclass 1 [Mass/volume] in Serum

307

1.50

1.90

1.6

1.4

g/l

7.0

6.6

0.53

215

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

541

1.38

1.89

1.1

1.2

—

271.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

217

1819

1.21

1.89

4.8

4.5

mmol/l

1.7

0.09

158

1345

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

147

1185

1.25

1.86

2.1

1.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

592

5361

1.12

1.86

1.5

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

213

1.60

1.85

1.1

1.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

245

1.56

1.84

2.5

2.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

384

1.44

1.83

1.4

1.3

nmol/l

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

125

991

1.27

1.83

3.2

2.4

g/l

3.1

0.02

783

(4062490)

310

1.49

1.82

1.6

1.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

4.17

1.82

3.0

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

286

1.51

1.81

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

666

1.33

1.81

1.5

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

563

1.36

1.80

1.4

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

393

3474

1.15

1.80

7.0

6.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

461

1.40

1.80

1.3

1.2

u/ml

9.9

4.7

0.92

202

(3014599) Egg white IgE Ab [Units/volume] in Serum

215

1.59

1.79

1.3

1.1

u/ml

25.1

2.1

0.46

(3037756) Immunofixation for Serum or Plasma

547

1.36

1.78

2.0

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

479

1.38

1.78

1.9

1.6

g/l

0.6

0.8

0.66

364

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

195

1630

1.21

1.77

1.7

1.6

—

(44806420)

2.03

1.74

1.8

2.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

219

1854

1.19

1.74

2.4

2.2

nmol/l

12.0

12.5

0.43

201

1640

(3009214) Lutropin [Units/volume] in Serum or Plasma

110

865

1.28

1.73

1.4

1.5

u/l

9.4

10.8

0.52

698

(3028192) IgG subclass 2 [Mass/volume] in Serum

306

1.48

1.72

1.6

1.4

g/l

3.0

2.9

0.18

215

(3024139) IgG subclass 3 [Mass/volume] in Serum

306

1.48

1.72

1.6

1.4

g/l

0.4

0.26

213

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

103

1.85

1.71

1.3

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.00

1.70

0.0

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

134

1082

1.25

1.70

2.1

2.0

ug/l

0.9

2.3

2.08

117

966

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

134

1.72

1.66

1.0

1.1

96.6

92.1

0.29

104

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

112

1.79

1.64

1.3

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

462

1.37

1.62

1.1

u/ml

17.6

5.0

0.43

180

(3011412) CD3 cells [#/volume] in Blood

303

1.46

1.60

1.7

2.4

e9/l

1.4

1.2

0.17

184

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

128

1.72

1.60

1.5

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.07

1.59

2.6

2.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

647

1.31

1.57

2.3

2.4

ug/min

99.8

108.1

0.07

401

(3000034) Microalbumin [Mass/volume] in Urine

247

1.50

1.57

3.4

2.9

mg/l

83.6

33.9

0.37

178

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

466

1.36

1.55

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

232

1.51

1.54

2.0

2.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.43

1.53

1.0

1.2

—

(3000492) Spirometry study

327

2891

1.14

1.53

1.6

1.4

—

(4094501)

774

1.27

1.52

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

554

1.32

1.52

2.6

3.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

200

1704

1.18

1.51

1.7

1.8

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

417

1.37

1.51

1.1

u/ml

8.5

4.4

0.54

178

(3052592) Norovirus Ag [Presence] in Stool

2.16

1.50

1.1

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.86

1.50

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

1.49

0.0

5.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.00

1.49

0.0

1.2

—

(3036603) Volume of Urine

194

1.55

1.48

1.8

1.4

2192.5

1923.1

0.50

(46235355) HIV 1 and 2 tests - Meaningful Use set

609

5604

1.10

1.45

1.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

117

1.71

1.44

1.3

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

603

1.30

1.44

3.4

3.6

58.3

57.1

0.38

603

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

364

3255

1.13

1.44

2.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.73

1.43

1.5

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

500

1.33

1.41

1.3

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

100

803

1.25

1.38

4.4

3.4

ratio

4.1

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

198

1.52

1.37

1.4

1.6

—

(3044927) Protein electrophoresis panel - Urine

272

1.44

1.37

1.4

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

108

877

1.24

1.36

1.4

1.2

u/ml

48.0

36.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.15

1.33

1.1

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

136

1.62

1.32

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

184

1.53

1.31

1.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

368

1.36

1.31

1.4

1.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.50

1.30

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

622

1.28

1.30

4.8

3.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

102

828

1.24

1.30

4.5

3.4

mg/l

36.0

71.0

0.99

671

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

360

1.37

1.30

1.4

1.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

129

1.63

1.29

1.2

1.4

nmol/l

29.2

31.5

0.10

108

(3006184) Hemoglobin [Mass/volume] in Capillary blood

623

1.27

1.29

1.9

2.3

g/l

134.4

129.8

0.76

457

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

268

1.42

1.27

3.7

2.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.09

1.27

1.1

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

501

1.30

1.26

1.4

nmol/l

0.2

0.4

1.42

384

(3005988) Vibrio sp identified in Specimen by Organism specific culture

362

1.36

1.26

1.4

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

242

2130

1.15

1.25

2.0

1.9

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

101

826

1.23

1.22

4.6

3.4

mg/l

48.2

62.0

0.50

669

(3048929) Epstein Barr virus Ab [Presence] in Serum

125

1045

1.20

1.21

1.4

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

109

899

1.22

1.21

2.9

2.4

g/l

1.1

1.0

0.10

793

(3020779) Urea [Moles/volume] in Serum or Plasma

286

2551

1.13

1.21

7.2

8.2

mmol/l

8.5

9.2

1.11

277

2441

(3020682) Albumin/Creatinine [Ratio] in Urine

899

8485

1.08

1.21

4.1

4.0

mg/mmol

27.6

9.0

0.47

575

5339

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

800

1.23

1.20

1.4

1.2

u/ml

24.4

3.3

0.45

(3045424) Erythrocytes [Presence] in Urine

515

1.29

1.19

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.75

1.18

1.1

1.3

—

(3017509) Phencyclidine [Presence] in Urine

2.31

1.18

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

658

1.25

1.18

1.4

1.2

u/ml

59.2

39.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

364

3301

1.11

1.17

1.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

223

1.44

1.16

1.1

iu/ml

6.6

10.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

394

1.32

1.16

1.4

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

615

1.26

1.16

5.6

5.8

iu/ml

148.1

587.5

1.23

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

308

1.37

1.15

1.3

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

377

1.33

1.15

1.3

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

360

1.34

1.15

1.4

1.5

—

(40768800) Prostate Pathology biopsy report

430

1.31

1.14

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

199

1.46

1.14

1.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

241

1.41

1.13

1.9

2.2

17.2

12.4

0.90

115

(3015076) Soybean IgE Ab [Units/volume] in Serum

183

1.48

1.13

1.1

u/ml

0.9

3.9

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.00

1.12

1.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

200

1.45

1.12

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

129

1092

1.19

1.11

2.1

1.9

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

159

1.51

1.11

2.0

1.8

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

362

1.33

1.11

1.4

—

(3012516) Albumin [Mass/volume] in Urine

854

8072

1.08

1.10

3.4

3.3

mg/l

890.0

332.9

1.52

548

5075

(3014111) Lactate [Moles/volume] in Serum or Plasma

276

2474

1.13

1.10

6.1

7.4

mmol/l

1.3

0.36

269

2385

(3015183) Erythrocyte sedimentation rate

176

1.48

1.10

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

477

1.28

1.10

1.3

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.95

1.08

2.8

2.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.95

1.08

1.3

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

811

1.21

1.08

1.4

1.3

u/ml

3.1

7.6

1.40

144

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

180

0.55

1.06

16.9

12.2

nmol/l

848.0

843.2

—

173

(3024522) Salmonella sp identified in Specimen by Organism specific culture

365

1.32

1.06

1.4

1.5

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

211

1.43

1.06

1.7

1.6

mmol/l

8.4

7.7

0.71

126

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

305

1.35

1.05

1.2

u/l

53.9

61.0

0.58

211

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

401

1.30

1.05

1.4

1.3

—

(3021788) Differential panel - Synovial fluid

508

1.26

1.04

1.5

1.6

—

(3020491) Glucose [Moles/volume] in Blood

212

1.42

1.03

1.7

1.8

mmol/l

6.7

0.01

136

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

114

1.58

1.02

1.3

1.1

g/l

0.3

0.10

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

474

1.27

1.01

1.2

1.4

u/l

27.8

27.9

0.01

386

(3000991) Gas panel - Venous blood

270

2433

1.12

1.00

6.7

8.9

—

(3035933) Granulocytes/100 leukocytes in Blood

110

0.45

1.00

1.2

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

361

1.31

0.99

4.8

6.8

mg/l

11.4

11.6

0.11

338

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

0.97

0.0

2.7

—

0.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

105

886

1.19

0.97

1.3

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

694

1.22

0.97

1.4

1.6

e6/l

1740.1

1443.7

0.08

563

(44806071)

1.95

0.97

1.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.95

0.97

3.0

2.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

124

1.54

0.96

2.7

2.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

100

841

1.19

0.96

1.1

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

105

888

1.19

0.95

1.2

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

797

1.20

0.94

3.1

2.3

g/l

0.2

0.0

0.43

739

(3050129) First trimester maternal screen panel - Serum or Plasma

104

880

1.19

0.94

1.5

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.78

0.94

1.5

2.2

umol/l

16.7

18.9

0.24

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.22

0.93

2.0

3.0

—

(3012501) Base excess in Blood by calculation

652

1.22

0.93

6.5

4.5

mmol/l

3.1

2.6

0.84

439

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

184

0.60

0.92

29.0

16.6

nmol/l

1740.1

1506.0

0.46

179

(3029634) Reagin Ab [Titer] in Serum by VDRL

453

0.75

0.92

1.9

—

3.8

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

191

1697

1.13

0.91

2.2

3.4

u/ml

246.3

51.9

0.60

185

1640

(3006462) Nitrate [Presence] in Urine

134

1.50

0.91

2.2

3.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.14

0.91

3.2

3.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

709

1.20

0.90

3.6

4.0

mmol/l

24.5

24.7

0.25

619

(3021387) Prolactin [Units/volume] in Serum or Plasma

130

1126

1.16

0.90

1.7

1.6

mu/l

289.3

305.5

0.29

118

1014

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

358

1.29

0.90

1.5

1.4

ug/l

2.7

4.1

0.86

317

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

474

1.25

0.89

1.3

1.2

u/ml

4.4

3.8

0.07

159

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

421

1.26

0.88

1.3

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

693

1.20

0.88

1.4

1.6

e6/l

8.7

27.0

1.25

532

(3014765) Yersinia sp identified in Stool by Organism specific culture

105

896

1.18

0.88

1.3

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

103

1.56

0.87

1.5

2.3

e6/l

122.5

283.3

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.82

0.85

1.1

—

(1616796) Gas panel - Central venous blood

632

1.21

0.85

4.7

4.0

—

(37021550) Renin [Units/volume] in Plasma --upright

1.67

0.85

1.4

1.3

mu/l

50.6

57.8

—

(21494814) CD8 cells/100 lymphocytes in Specimen

121

1.49

0.82

2.1

2.0

—

(4211845)

146

1.44

0.82

2.1

3.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

391

3632

1.09

0.82

2.1

—

(3028707) Methadone [Presence] in Urine by Screen method

533

0.79

0.81

3.5

2.6

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.88

0.81

1.2

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

111

959

1.16

0.81

1.6

iu/ml

25.2

7.3

0.31

191

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

375

3479

1.09

0.81

4.4

4.3

32.8

32.5

0.23

261

2378

(3028626) Oxygen [Partial pressure] in Capillary blood

793

1.18

0.80

5.3

5.1

kpa

8.6

0.14

734

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

215

1.35

0.80

1.1

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

105

905

1.17

0.80

1.3

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

249

2270

1.10

0.79

1.3

1.4

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

0.00

0.79

0.0

1.3

—

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.82

0.79

1.2

—

(3035880) pH of Pleural fluid

139

1.44

0.79

1.5

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

321

1.28

0.79

2.8

4.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.67

0.78

2.0

1.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

823

1.17

0.78

2.8

2.2

g/l

38.3

37.8

0.30

716

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

520

1.22

0.77

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.77

0.76

1.3

1.6

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.76

0.0

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

332

1.27

0.76

1.0

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

270

1.30

0.76

1.5

1.4

e6/l

104612.1

93584.2

0.05

153

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.70

0.75

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.54

0.75

2.2

1.5

ug/l

7.9

8.8

0.79

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

315

1.27

0.74

1.3

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

262

1.30

0.74

3.0

3.9

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

470

1.22

0.72

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.61

0.72

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

553

1.20

0.71

1.6

1.7

—

(3010421) pH of Blood

775

1.17

0.71

5.9

4.2

7.4

0.93

645

(3000285) Sodium [Moles/volume] in Blood

1.75

0.71

2.1

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.58

0.71

1.0

—

(3006598) pH of Arterial cord blood

1.58

0.71

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.58

0.71

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.58

0.71

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

444

1.22

0.71

1.2

u/l

44.0

32.7

0.34

380

(3020191) Ethanol [Moles/volume] in Serum or Plasma

238

1.31

0.70

1.3

1.4

promille

1.1

1.2

0.21

187

(3000012) Reticulocyte production index

135

1.41

0.69

1.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

741

1.16

0.68

3.0

2.3

g/l

0.0

0.00

686

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

248

1.29

0.68

1.3

1.4

mmol/l

10.2

12.3

1.11

(3022689) Creatine [Moles/volume] in Urine

1.56

0.68

2.0

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.67

0.68

1.0

1.4

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.53

0.68

2.6

2.9

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

687

1.17

0.67

1.2

1.4

mmol/l

3.8

3.7

0.40

650

(3003740) Influenza virus B Ag [Presence] in Specimen

521

1.19

0.66

1.1

—

(3025130) Human papilloma virus identified in Specimen

430

1.21

0.66

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

453

4275

1.07

0.65

3.1

3.0

ug/l

0.7

0.54

302

2767

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

735

1.16

0.65

3.0

2.3

g/l

0.0

0.00

685

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.59

0.65

7.1

3.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

109

961

1.14

0.65

1.9

1.8

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

154

1.37

0.65

1.0

1.4

umol/l

4.0

4.6

0.25

144

(3017704) Immunofixation for Urine

154

1.37

0.65

2.6

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

204

1867

1.10

0.63

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

626

1.17

0.63

3.4

3.6

mg/l

17.2

25.8

2.20

390

(3004809) Band form neutrophils/100 leukocytes in Blood

460

1.20

0.63

2.7

3.5

1.5

1.3

0.14

362

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

160

1448

1.11

0.62

7.5

10.1

mmol/l

24.4

24.2

0.23

149

1361

(44790047)

360

1.22

0.62

1.3

1.5

—

(44790048)

360

1.22

0.62

1.3

1.5

—

(44790049)

360

1.22

0.62

1.3

1.5

—

(44806118)

360

1.22

0.62

1.3

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

360

1.22

0.62

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

261

1.27

0.62

1.4

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

306

1.24

0.62

1.5

1.4

e6/l

2339.7

2370.9

0.01

217

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

833

1.14

0.62

1.6

1.7

—

(3042733) HLA Ab [Presence] in Serum

104

0.58

0.61

4.0

4.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

180

1642

1.10

0.61

1.5

—

(3008898) HLA-B27 [Presence]

124

1109

1.12

0.60

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

105

1.43

0.60

1.1

—

(3042631) Mycobacterium sp identified in Specimen

353

1.22

0.60

2.8

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

236

1.27

0.59

1.7

1.5

g/l

0.9

0.00

236

(40768441) Liver Pathology biopsy report

236

1.27

0.59

1.7

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

345

3241

1.07

0.59

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.51

0.58

2.5

1.6

—

(3023410) Appearance of Cerebral spinal fluid

318

1.23

0.58

1.5

1.9

—

(4281824)

332

0.78

0.58

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

102

904

1.13

0.58

2.7

3.6

u/ml

0.4

0.23

514

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

376

0.80

0.58

1.5

1.7

—

1136.0

—

(3019174) dRVVT (LA screen)

1.72

0.57

1.2

1.1

—

(3023419) Bacteria identified in Sputum by Culture

364

1.21

0.57

2.6

2.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

106

1.42

0.57

1.1

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

1.48

0.57

1.1

1.7

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

158

1.33

0.57

1.0

1.1

u/l

87.0

83.3

0.11

127

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

540

1.17

0.56

1.4

1.7

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.57

0.56

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.56

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

775

1.14

0.55

1.9

iu/l

3.1

4.8

1.20

275

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

107

1.40

0.55

1.1

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

159

1.32

0.55

1.0

1.1

u/l

13.2

25.0

—

121

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

786

1.14

0.54

1.2

1.5

mg/l

469.7

524.9

0.67

747

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.42

0.54

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

1.45

0.53

1.9

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

405

1.19

0.52

1.5

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.52

0.52

1.2

—

(3018133) Calcium [Moles/volume] in Urine

1.41

0.51

2.6

2.4

mmol/l

2.4

2.7

—

(4034850)

979

0.89

0.51

7.9

9.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.46

0.50

1.2

4.0

umol/l

42.8

43.4

—

(40768795) Lymph node Pathology biopsy report

288

1.22

0.50

1.3

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

911

8837

1.04

0.49

3.3

mmol/l

7.5

0.18

788

7502

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

400

1.18

0.48

1.6

1.3

mmol/l

7.5

7.3

0.18

294

(3045414) Leukocytes [Presence] in Urine

150

1377

1.09

0.48

1.9

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

217

1.25

0.48

1.4

2.5

e6/l

388.4

550.4

1.23

180

(40761536) Microorganisms panel - Urine sediment

269

2529

1.07

0.47

3.8

3.9

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

166

0.72

0.47

1.2

1.7

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

128

1.33

0.47

1.5

2.2

ug/l

20.0

81.2

0.49

113

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.49

0.47

5.9

3.0

—

(3051611) Lipemic interference index of Serum or Plasma

290

1.21

0.47

2.6

3.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

102

1.37

0.47

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

523

1.15

0.46

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

182

1.27

0.46

1.7

1.4

pmol/l

99.7

212.4

—

(3016018) Differential panel - Cerebral spinal fluid

337

1.19

0.46

1.5

1.7

—

(21494434) Karyotype in Bone marrow

246

1.22

0.45

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

237

1.23

0.45

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

237

1.23

0.45

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

237

1.23

0.45

1.2

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

210

1.24

0.45

1.6

2.5

e9/l

0.2

0.42

180

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

104

1.35

0.43

1.1

—

5.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

239

1.22

0.42

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

239

1.22

0.42

1.2

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

462

1.15

0.42

1.2

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

509

1.14

0.42

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

149

1.28

0.41

2.2

2.1

umol/l

29.9

28.4

0.24

144

(3028679) Herpes simplex virus Ab [Presence] in Serum

167

1.26

0.41

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

240

1.21

0.41

1.2

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.41

0.0

3.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

222

1.22

0.41

2.3

2.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

455

1.14

0.40

1.4

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.34

0.39

1.4

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.43

0.39

6.2

10.3

—

(3021901) Oxygen saturation in Capillary blood

503

1.14

0.39

3.1

3.3

—

(3044941) Cell count panel - Synovial fluid

456

1.14

0.39

1.4

1.5

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.39

0.0

2.4

—

3.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.39

0.38

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

326

1.17

0.38

1.1

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

215

1.21

0.38

1.7

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

203

0.79

0.38

1.4

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

571

1.12

0.37

1.4

1.5

u/ml

107.3

116.1

0.23

102

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

136

0.73

0.37

1.3

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

124

1146

1.08

0.37

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

179

1.23

0.37

1.0

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

112

0.71

0.37

1.3

6.6

mg/l

116.8

75.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

257

0.82

0.37

1.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

116

0.69

0.36

1.4

1.2

—

(4015189)

1.39

0.36

1.9

2.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

198

1.21

0.36

1.2

1.3

—

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

107

985

1.09

0.36

1.3

miu/ml

283.9

220.2

0.83

473

(40767503) Oxygen content in Capillary blood by calculation

593

1.12

0.35

2.7

2.6

17.4

16.3

1.19

301

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

208

1.20

0.35

1.3

—

(3045788) Cell count panel - Pleural fluid

245

1.19

0.35

1.6

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

301

1.16

0.35

1.1

—

(3022621) pH of Urine by Test strip

203

1918

1.06

0.34

3.1

2.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

490

1.12

0.34

1.2

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.33

0.33

1.0

1.7

pmol/l

26.8

32.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

177

0.79

0.33

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

625

1.11

0.33

1.4

1.3

u/ml

299.1

259.2

0.43

380

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

397

1.14

0.33

1.1

u/ml

0.2

0.3

—

102

(3033799) Differential panel - Peritoneal fluid

0.67

0.32

1.3

2.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

263

0.84

0.32

1.3

1.4

39.1

34.8

0.21

154

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

105

973

1.08

0.31

2.0

2.3

ug/l

246.0

647.7

1.10

904

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

496

0.89

0.31

1.0

1.1

iu/ml

142.3

1159.3

—

117

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

129

1.24

0.30

1.2

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.33

0.30

1.4

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

120

1.25

0.30

1.0

1.2

—

(40765096) Chromosome analysis panel by Banding

1.29

0.30

1.2

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

726

1.09

0.29

1.5

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

401

1.12

0.29

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

249

0.84

0.29

1.2

1.1

mg/l

27.5

41.7

2.77

209

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.23

0.29

1.1

1.2

—

(40768793) Breast Pathology biopsy report

743

0.91

0.29

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

287

2757

1.04

0.28

1.8

1.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

121

1.24

0.28

2.0

1.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

167

1.20

0.28

1.0

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

651

1.09

0.28

1.3

1.6

—

(40768446) Kidney Pathology biopsy report

129

0.77

0.28

1.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

149

1.21

0.27

1.1

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

346

1.13

0.27

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

595

0.91

0.27

1.6

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

739

1.08

0.27

1.5

1.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.25

0.27

1.0

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

662

1.09

0.27

1.4

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

299

1.14

0.27

1.0

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

306

2948

1.04

0.27

3.6

3.2

—

(3004775) Volume in Urine collected for unspecified duration

224

1.16

0.27

2.2

742.4

637.5

0.54

154

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

182

0.82

0.26

1.0

1.1

u/l

0.9

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.19

0.26

1.9

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

178

1.18

0.26

2.0

2.8

41.4

41.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

120

1129

1.07

0.26

1.4

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.67

0.25

1.0

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

160

1.19

0.25

2.3

2.1

umol/l

1.9

0.02

151

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

235

1.15

0.25

1.6

1.2

titre

602.0

156.0

—

(3051593) INR in Capillary blood by Coagulation assay

114

1.23

0.25

8.5

12.7

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

236

1.15

0.24

1.2

1.3

u/ml

0.2

0.5

—

(3001186) Copper [Moles/volume] in Serum or Plasma

0.74

0.24

1.0

1.3

umol/l

25.4

17.5

—

(3044007) Cell count panel - Peritoneal fluid

0.72

0.24

2.5

2.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

274

1.13

0.24

2.2

3.2

51.1

56.4

0.73

181

(3024928) Oxygen saturation in Venous blood

610

0.92

0.23

2.6

3.6

—

(3052851) Hemolysis interference index of Serum or Plasma

862

1.07

0.23

2.8

3.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.28

0.23

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.28

0.23

1.4

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

134

1.19

0.22

3.6

4.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

0.74

0.22

1.3

61.7

49.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

189

0.85

0.22

1.3

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

163

1.17

0.21

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

14.1

—

(3024932) HLA-DR beta [Type]

104

0.77

0.21

1.3

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

429

0.91

0.21

1.7

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

177

0.85

0.21

1.6

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

512

0.92

0.21

1.5

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.21

0.0

4.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

272

0.88

0.20

1.6

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

134

0.82

0.20

1.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

934

0.94

0.20

2.3

2.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

615

0.93

0.20

1.1

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

615

1.07

0.20

3.3

3.1

umol/l

31.6

36.4

0.88

530

(3013762) Body weight Measured

0.00

0.20

0.0

1.3

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.25

0.20

2.2

7.0

g/mol

7258.6

65.7

—

(3004451) EKG impression Narrative

136

1.18

0.20

1.5

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

113

0.80

0.20

1.6

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

1.20

0.19

1.0

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

520

1.08

0.19

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.22

0.19

1.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

222

1.13

0.19

1.5

2.4

e6/l

898.4

730.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

337

1.10

0.19

1.4

1.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

581

0.93

0.18

1.5

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

676

1.07

0.18

1.7

e6/l

13196.6

13067.9

0.01

488

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

132

0.83

0.18

1.9

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

132

0.83

0.18

1.9

1.8

—

(3005033) Fetal Nuchal fold Thickness US

580

0.93

0.18

1.5

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

269

0.89

0.18

1.5

1.4

e6/l

4955.2

78353.7

1.29

188

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

845

1.05

0.17

1.8

—

(1002224) Polysomnography panel

129

1237

1.04

0.17

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

631

1.06

0.16

1.5

—

19.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

234

1.11

0.16

1.1

—

(40768806) Pleura Pathology biopsy report

263

1.10

0.16

1.7

1.5

—

(3017732) Neutrophils [#/volume] in Blood

217

2106

1.03

0.16

2.6

2.9

e9/l

4.3

4.1

0.75

166

1678

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

162

0.86

0.16

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

162

0.86

0.16

1.4

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

162

0.86

0.16

1.8

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

162

0.86

0.16

1.8

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

162

0.86

0.16

1.5

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

162

0.86

0.16

1.8

1.7

—

(3051651) Icteric interference index of Serum or Plasma

183

0.87

0.16

2.9

3.5

—

(3029075) Extractable nuclear Ab panel - Serum

1.20

0.16

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

179

1732

1.04

0.16

1.7

—

(3048879) Bone marrow aspiration report

1.11

0.16

2.3

2.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

130

0.85

0.16

2.1

3.1

ug/l

2.2

1.4

0.26

122

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

151

0.86

0.15

1.2

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

151

0.86

0.15

1.2

1.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.10

0.15

1.0

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.21

0.15

1.2

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.15

0.15

1.9

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.15

0.15

1.8

2.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

769

0.95

0.15

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

286

0.91

0.15

1.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.81

0.14

2.1

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

132

1367

0.96

0.14

1.6

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

626

1.06

0.14

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

429

0.93

0.14

1.2

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

103

1.17

0.13

1.3

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.82

0.13

1.3

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

393

1.07

0.13

1.2

—

(3047189) Immunofixation for 24 hour Urine

132

1.14

0.13

2.9

1.6

—

(3024471) HLA-A [Type]

106

0.85

0.13

1.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

190

0.89

0.13

1.0

ng/l

606.5

699.5

0.42

120

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

345

1.07

0.12

1.4

1.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

743

0.95

0.12

1.5

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

317

1.07

0.12

1.4

1.7

—

(3019977) pH of Arterial blood

143

1.12

0.11

1.6

2.9

7.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

153

1.11

0.11

1.9

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

291

0.93

0.11

1.8

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

163

1.10

0.10

1.3

nmol/l

136.8

132.4

0.18

163

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

270

1.07

0.10

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

270

1.07

0.10

1.4

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

270

1.07

0.10

1.4

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

193

1.09

0.10

1.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.09

0.09

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.09

0.09

1.4

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

706

0.96

0.09

2.3

2.1

—

(4027681)

186

0.91

0.09

1.1

1.2

—

(3012441) Differential panel - Pleural fluid

262

1.07

0.09

1.6

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.11

0.09

1.8

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

705

0.96

0.08

1.5

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

331

1.06

0.08

1.4

1.5

—

24.7

—

(3017569) Oxygen content in Arterial blood

134

0.90

0.08

1.1

2.4

—

(3003694) ABO and Rh group [Type] in Blood

840

8336

1.01

0.08

1.4

1.5

—

(3002619) Bacteria identified in Specimen by Culture

1.05

0.08

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.82

0.08

1.2

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

0.82

0.08

1.8

2.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

704

0.97

0.08

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

704

0.97

0.08

1.5

1.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

185

0.92

0.08

1.4

1.6

umol/l

44.7

23.3

1.32

177

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.09

0.08

1.1

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.06

0.08

1.0

—

(1761868) Lipid panel - Serum or Plasma

1066

10723

0.99

0.08

3.0

2.7

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

0.81

0.07

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

611

0.97

0.07

1.9

2.2

nmol/l

0.8

0.12

505

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

702

0.97

0.07

1.5

1.4

—

(3011648) Oxygen content in Venous blood

245

0.94

0.07

2.3

3.9

9.6

11.2

0.83

245

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.82

0.07

1.1

1.8

u/l

11.7

53.5

—

(3020650) Glucose [Presence] in Urine

1.06

0.07

1.4

1.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.89

0.06

1.0

2.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

336

0.95

0.06

1.4

1.6

45.5

58.9

1.34

209

(3027944) Amphetamines [Presence] in Urine

120

1175

1.02

0.06

2.1

1.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

121

1185

1.02

0.06

1.3

1.7

mg/l

3.3

4.0

0.45

834

(3009871) Measles virus Ab [Titer] in Serum

103

0.87

0.06

1.4

1.8

—

(3034426) Prothrombin time (PT)

105

0.86

0.06

1.1

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

152

1494

1.02

0.06

3.9

4.8

mmol/l

24.5

24.0

1.31

136

1358

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

109

1.10

0.06

2.3

3.1

—

125.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

286

2892

0.99

0.06

1.7

—

(3011288) Drugs identified in Urine by Screen method

819

0.98

0.05

3.0

2.7

—

(21494755) Public health laboratory ask at order entry panel

295

2979

0.99

0.05

1.3

—

(3008295) Osmolality of Serum or Plasma

333

0.96

0.05

1.5

mosm/kgh2o

281.3

280.3

0.10

256

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

130

1.08

0.04

1.1

miu/ml

1628.6

1504.6

0.17

130

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

595

1.03

0.04

1.9

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

397

1.03

0.04

1.3

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

655

0.98

0.04

1.6

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

219

1.05

0.04

2.2

2.3

u/field

0.3

2.0

—

100

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

231

0.95

0.04

1.0

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

231

0.95

0.04

1.1

—

(3028433) Virus identified in Specimen by Culture

101

1.09

0.04

1.0

1.2

—

(3027008) Opiates [Presence] in Urine

118

1197

0.99

0.04

2.1

2.0

—

(3014271) Vancomycin [Susceptibility]

121

1.07

0.03

2.8

2.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

210

0.95

0.03

1.1

1.2

—

(4198724)

129

0.93

0.03

1.8

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

458

1.03

0.03

1.4

—

(3016879) Cocaine [Presence] in Urine

109

1105

0.99

0.03

2.2

2.0

—

(3028300) Cannabinoids [Presence] in Urine

119

1203

0.99

0.02

2.1

2.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

152

1.05

0.02

1.1

2.1

—

(4268621)

319

0.97

0.02

2.4

2.2

—

(3003181) Sodium [Moles/volume] in Urine

511

1.02

0.02

1.5

mmol/l

62.9

64.0

0.06

411

(3041806) Other cells [#/volume] in Blood by Manual count

103

1.07

0.02

1.2

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

113

1.06

0.01

1.3

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

118

1190

0.99

0.01

2.1

2.0

—

(3024263) Appearance of Synovial fluid

147

0.95

0.01

1.7

1.9

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

153

1.05

0.01

1.7

u/field

2.3

3.3

—

114

(3004716) Salmonella sp identified in Stool by Organism specific culture

166

1650

1.01

0.01

1.3

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

144

1.04

0.00

1.3

2.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

166

0.96

0.00

1.4

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

344

1.02

0.00

2.5

2.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.01

0.00

1.0

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

327

1.01

0.00

1.1

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

766

1.01

0.00

1.3

1.5

pmol/l

61.8

175.4

3.96

751

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

347

1.01

0.00

1.9

2.3

mg/l

27.0

22.7

0.17

(4146454)

292

0.99

0.00

2.9

2.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

118

1.02

0.00

3.7

2.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

505

1.01

0.00

3.0

3.2

nmol/l

0.9

0.8

0.17

390

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

115

1.04

0.00

4.8

4.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

198

1.01

0.00

1.4

u/ml

16.0

20.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

917

1.00

0.00

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

185

0.97

0.00

1.3

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

229

1.00

0.00

1.5

1.6

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.00

0.00

1.1

1.0

—

(3032641) Amino acids panel - Urine

0.00

0.0

1.6

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

3.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

119.3

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.6

—

1.5

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

7.5

—

95.7

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.93

0.00

4.6

2.9

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.93

0.00

9.2

5.7

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1296.7

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.00

0.00

1.1

1.0

—

(3049233) Organic acids panel - Urine

0.00

0.0

1.6

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.91

0.00

1.0

1.1

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.95

0.00

1.0

1.3

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

0.00

0.0

1.0

—

157.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.5

—

2494.4

—

(3006576) Bicarbonate [Moles/volume] in Blood

0.92

0.00

4.5

7.4

mmol/l

26.7

24.7

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.02

0.00

1.4

1.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.94

0.00

6.2

7.8

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.2

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.00

0.00

1.1

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.00

0.00

1.1

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.02

0.00

3.0

1.8

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.02

0.00

1.0

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA	0.963 [0.86, 1.08]	0.536
Birth year	0.995 [0.99, 1.0]	0.208

During the follow-up period (1.1.1998 — 31.12.2019), 979 out of 13789 females with CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA	1.126 [1.0, 1.27]	0.046
Birth year	0.987 [0.98, 1.0]	0.009

During the follow-up period (1.1.1998 — 31.12.2019), 1156 out of 9406 males with CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA.

N-year risk	Females	Males
1	0.066%	0.222%
5	0.478%	1.371%
10	1.339%	3.372%
15	2.605%	6.383%
20	4.503%	10.786%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA – Haemangioma and lymphangioma, any site

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Haemangioma and lymphangioma, any site

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints